Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000778.SZ
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 16.10 1.45 1.25
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 269.83 44.44 12.02
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.70 6.47 6.42
Cash -34.70 1.73 2.64
Capex 11.17 -0.06 -0.07
Free Cash Flow 183.17 -0.55 0.19
Revenue 32.29 2.29 1.73
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -31.75 0.04 0.06
Operating Margin -20.36 < 0.005 0.01
ROA -34.16 < 0.005 < 0.005
ROE -35.11 < 0.005 0.01
ROIC 31.88 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000778.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000778.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000778.SZ is permitted for members.